JCO Precision Oncology Issues Research Articles in 2022 Annual Edition
April 25, 2022
April 25, 2022
ALEXANDRIA, Virginia, April 25 -- JCO Precision Oncology, a peer-reviewed journal that says it advances the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer from the American Society of Clinical Oncology, published research articles, including the following topics, in its 2022 annual edition:
CASE REPORTS:
* Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Posi . . .
CASE REPORTS:
* Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Posi . . .